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Abstract
Functionalized superparamagnetic iron oxide nanoparticles are frequently used to develop vehicles for drug delivery,
hyperthermia, and photodynamic therapy and as tools used for magnetic separation and purification of proteins or for
biomolecular imaging. Depending on the application, there are various possible covalent and non-covalent approaches
for the functionalization of particles, each of them shows different advantages and disadvantages for drug release and
activity at the desired location.
Particularly important for the production of adsorptive and covalent bound drugs to nanoparticles is the
pureness of the involved formulation. Especially the covalent binding strategy demands defined chemistry of
the drug, which is stabilized by excess free amino acids which could reduce reaction efficiency. In this study,
we therefore used tangential flow filtration (TFF) method to purify the drugs before the reaction and used
the frequently applied and clinically available recombinant tissue plasminogen activator (tPA; Actilyse®) as a
proof of concept. We then coupled the tPA preparation to polyacrylic acid-co-maleic acid (PAM)-coated
superparamagnetic iron oxide nanoparticles (SPIONs) using an amino-reactive activated ester reaction and
compared these particles to PAM-coated SPIONs with electrostatically adsorbed tPA.
Using dynamic light scattering (DLS) and pH-dependent electrokinetic mobility measurements, we showed that surface
properties of the SPIONs were significantly greater affected after activation of the particles compared to the adsorption
controls. Different in vitro assays were used to investigate the activity of tPA after coupling to the particles and purification
of the ferrofluid. Covalent linkage significantly improves the reactivity and long-term stability of the conjugated SPION-tPA
system compared to simple adsorption. In conclusion, we have shown an effective way to produce SPIONs with covalent
and non-covalent ultra-filtrated drugs. We showed that using activated ester reaction, immobilization of the protein was
significantly better than in adsorptive approaches. Investigation of those functionalized SPIONs revealed diverging
attributes, which should be taken into account when developing nanoparticles for different applications.
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Background
The functionalization of nanoparticles is an important
process to generate customized tools for a wide variety
of biological and therapeutic applications [1–11]. While
the core material particularly determines the physical
parameters of the particle system, e.g., magnetic and op-
tical properties, the choice of the shell biomolecules,
e.g., proteins, DNA, or RNA, especially defines the
surface properties, and thus, their biological behavior
[12–14]. Meanwhile, there are plenty of possibilities to
conjugate these biomolecules to the particle surface
using covalent and non-covalent approaches [15]. How-
ever, the surface fabrication has to be done very carefully
as it is the most critical factor which defines the proper-
ties and effects of the particles. In some cases, it might
be advisable to produce particles using different tech-
niques to obtain non-covalent and covalent conjugations
and compare the results. While adsorptive binding bears
the risk of premature drug release and poor reproduci-
bility, covalent binding could possibly influence drug
structure and efficacy [16, 17]. Furthermore, it cannot be
assumed that loading efficacy is the same in covalent
and non-covalent approaches. However, despite numer-
ous published studies describing the production and effi-
ciency of particles for the treatment of diseases, a direct
comparison between different conjugation strategies is
not always performed.
In this study, we directly compared the binding of a
protein commonly used for the treatment of specific dis-
eases of the circulatory system, the most important
cause of premature death in Europe [18]. The main
emergency treatment drug for ischemic stroke is the tis-
sue plasminogen activator (tPA), a natural enzyme which
catalyzes the conversion of plasminogen to plasmin and
thereby dissolves clots. This protein suffers from very
low bioavailability and therefore has to be administered
in relatively high doses, which can cause potentially ser-
ious side effects like internal bleedings. Coupling of the
protein to iron oxide nanoparticles for magnetic drug
targeting to blood clots could provide higher bioavail-
ability and could help to overcome the drawbacks
caused by this high dosage. However, it is also important
to ensure that the enzyme can still penetrate into the
clot in order to get deep fibrinolysis.
Here, we coupled a clinically available recombinant
preparation of tPA (Actilyse®) to polyacrylic acid-co-ma-
leic acid (PAM)-coated SPIONs using an amino-reactive
activated ester reaction. Similar approaches have been
taken before [19]; however, the fact that Actilyse® is sta-
bilized by excess arginine which may influence reaction
efficacy was not always taken into account. Conse-
quently, the question whether binding of the protein is
adsorptive or covalent is still unanswered. Therefore, we
first developed a tangential flow filtration (TFF) method,
a highly effective purification method for lyophobic col-
loids [20], to quickly purify the protein of any amino
group-bearing by-products which might compromise re-
action efficacy. We then covalently attached the protein
to the particles and compared the particles with adsorp-
tion under the same conditions. We clearly demon-
strated the reaction efficacy and the concentration and
reaction time-dependent influence on tPA binding on
the hydrodynamic size and surface characteristics of the
particles using DLS and pH-dependent electrokinetic
mobility assays. Although the particles are able to bind a
certain amount of protein without further activation, co-
valent linkage significantly improves the reactivity of the
conjugated SPION-tPA system compared to simple ad-
sorption. This leads to tPA-concentration and reaction
time-dependent changes in the surface properties, which
is reflected by coinciding changes in colloidal stability.
We furthermore used different in vitro assays to prove
the activity of the protein after particle binding and
showed that tPA is still active after coupling to the parti-
cles. Particles with covalently bound tPA were signifi-
cantly more effective than their adsorptive bound
counterparts. This strategy can also be used to functio-
nalize nanoparticles with other proteins to target other
diseased tissues.
Methods
Materials
Iron(II) chloride tetrahydrate (FeCl2⋅4H2O), hydroxy-
lammonium chloride, bovine serum albumin (BSA), and
Eppendorf ultrafiltration tubes with a molecular weight
cutoff (MWCO) of 3 kDa were purchased from Merck
(Darmstadt, Germany). Iron(III) chloride hexahydrate
(FeCl3⋅6H2O), dialysis tubes (Spectrapor 6, MWCO
8 kDa), ammonium chloride, formic acid, hydrochloric
acid 25 %, ethylcarbodiimide hydrochloride (EDC), N-
hydroxysuccinimide (NHS), sodium thiosulfate, silver ni-
trate, sodium carbonate, and ammonia solution 25 %
were supplied by Roth (Karlsruhe, Germany). Propidium
iodide (PI), sodium citrate, triton X-100, ninhydrin,
MES, HEPES, and poly(acrylic acid-co-maleic acid) solu-
tion (Mw = 3000 Da) were purchased from Sigma-
Aldrich (St Louis, MO, USA). Ringer’s solution was
bought from Baxter Healthcare (Zurich, Switzerland).
Annexin V-FITC (AxV), Hoechst 33342 (Hoe), and
DiIC1(5) (hexamethylindodicarbocyanine iodide dye [DiI])
were purchased from Thermo Fisher Scientific (Waltham,
MA, USA).
Synthesis of Nanoparticles
Synthesis of In Situ-Coated Poly(acrylic acid-co-maleic acid)
Ferrofluid (PAM-SPIONs)
Poly(acrylic acid-co-maleic acid)-coated superparamag-
netic iron oxide nanoparticles (PAM-SPIONs) were
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synthesized using a previously reported protocol [21].
Briefly, iron oxide nanoparticles were synthesized by co-
precipitation of iron(II) and iron(III) at a stoichiometric
ratio of 1:2 under argon atmosphere at 80 °C. After puri-
fication by dialysis, the particles were coated with PAM.
The particles were therefore diluted in a 25 % (w/V)
solution of PAM to a total iron concentration of 5 g/L.
The pH was adjusted to pH 6.5 using sodium hydroxide
solution (5.0 N), and the suspension was stirred for 24 h.
Excess polymer was removed by multiple centrifugation
and resuspension in ultrapure water.
Purification of the tPA Formulation
In order to remove the arginine excess from the tPA for-
mulation, we established a TFF method. The protein
alone is not stable in water or isotonic salt solutions.
Consequently, early attempts using dialysis or diafiltra-
tion were not successful. In this study, we used a
Spectrum Labs KrosFlo® Research II TFF unit (Spec-
trumLabs, Los Angeles, California) with modified polye-
thersulfone (mPES) hollow fibre filters (molecular
weight cut off 30 kDa). After dissolving the lyophilised
tPA in 0.3 M HEPES buffer (pH 7.4) (1 mg/mL), the
solution was filtered using 0.3 M HEPES buffer (pH 7.4)
as filtration medium. The removal of free amino acids
was shown using ninhydrin reaction from the filtrate
samples. After 20 min of filtration with a constant filtra-
tion gradient of 1 mL/min, no free amino acids were de-
tected in the filtrate. The protein solution was then
concentrated to the original volume and stored at 4 °C.
Synthesis of PAM/Tissue Plasminogen Activator Hybrid
Nanoparticles (tPA@PAM-SPIONs)
PAM-SPIONs were diluted to a concentration of
1.0 mg/mL total iron in MES buffer 0.05 M pH 6.3 at 4 °
C. 19.9 mg/mL EDC-HCl and 24.0 mg/mL NHS per mL
were then added to activate the carboxyl groups at 4 °C
in the dark for 1 h [22]. The particles were then centri-
fuged twice to remove excess activator and resuspended
in 0.1 M MES buffer pH 6.3. The adsorption control was
processed accordingly (buffers and centrifugation), but
no EDC or NHS was added. The respective amount of
protein (between 25 and 500 μg tPA per mL, reflecting a
tPA to iron weight ratio of 0.3–6.25 %) was then added
to the activated or non-activated particles. The mixture
was stirred for 3 h at 4 °C. The particles were centri-
fuged and resuspended in ultrapure water two times and
then resuspended in the original volume of ultrapure
water. The supernatants of the washing steps were col-
lected, lyophilized, and redissolved in 500 μL water for
determination of unbound tPA. The amount of unbound
tPA was determined using Coomassie and silver staining,
respectively. In short, 25 μL samples and TPA standard,
respectively, were denatured in 6× SDS-PAGE sample
loading buffer (G-Biosciences, USA) at 95 °C for 5 min
before being separated electrophoretically with a 12.5 %
SDS polyacrylamide gel at 30 mA for 2 h. After staining
with Commassie staining solution (0.5 % (w/V), Coo-
massie Brilliant Blue G250 (Biorad), 50 % ethanol, 7 %
acidic acid) for 2 h and destaining with 20 % methanol/
7 % acidic acid, the gels were scanned and protein bands
were quantified using image J, and for silver staining,
SDS polyacrylamide gels were incubated in fixer solution
(40 % ethanol, 10 % acetic acid) for 30 min, washed
twice in 30 % ethanol, and twice with water. Gels were
incubated in sensitizer solution (0.02 % Na2S2O3) for
1 min, washed with water, and incubated with silver ni-
trate solution (100 mM AgNO3, 0.02 % formaldehyde) for
20 min, washed with water, and developed (2 % Na2CO3,
0.04 % formaldehyde) until staining is sufficient. Subse-
quently, gels were washed with water, scanned, and quan-
tified using image J.
Characterization of Nanoparticles
Nanoparticle Quantification
The total iron content was determined using an Agilent
4200 microwave plasma-atomic emission spectrometer
(MP-AES; Agilent Technologies, Santa Clara, CA).
Three different aliquots (50 μL) of the respective ferro-
fluid were dissolved in 950 μL of hydrochloric acid 25 %.
The iron content was then determined with MP-AES
using an iron solution as external standard. The calibra-
tion curve was prepared with iron concentrations ran-
ging from 0.05 to 2.5 mg/L. If the coefficient of
determination (R2) in this given range exceeded 0.999,
we proceeded with the sample measurements, which
were performed in triplicates.
Dynamic Light Scattering (DLS) and Zeta Potential
Measurements
Size measurements were performed with a Nanophox
(Sympatec, Clausthal-Zellerfeld, Germany) photon cross-
correlation spectrometer. The respective suspensions
were diluted to a total iron concentration of 25 μg/mL
with ultrapure water. They were measured precisely 60 s
after sonication in triplicate at 25 °C. The hydrodynamic
sizes and zeta potentials in cell culture media were de-
termined using a Malvern Zetasizer Nano ZS (Malvern
Instruments, Worcestershire, England). The particles
were diluted to a total iron concentration of 25 μg/mL
with RPMI 1640 cell culture (without FCS) and measured
in triplicate at 25 °C. pH-dependent electrokinetic mobil-
ity measurements were also done with the Zetasizer. Here,
the particle suspension was diluted to 25 μg/mL total iron
in 10 mM sodium chloride solution which had been ad-
justed to the respective pH using either hydrochloric acid
or sodium hydroxide solution. The particles were mea-
sured precisely 60 s after sonication.
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Fourier Transform Infrared Spectroscopy (FTIR)
Five hundred microliters of the respective particles were
lyophilized overnight. Spectra of the respective samples
were then taken with a BRUKER Alpha FTIR spectrom-
eter (Bruker, Billerica, MA, USA) operated in attenuated
total reflection mode from 4000 to 400 cm−1 using a
step size of 0.5 cm−1.
Determination of tPA Activity with S-2288
The amidolytic activity of tPA was measured spectroscop-
ically using the chromogenic substrate S-2288™ (Chromo-
genix, Nr. 8205239, USA). Freshly prepared tPA stock
solution (1 mg/mL in water; Actilyse Cathflo, Boehringer
Ingelheim, Germany) was diluted to 0.1 mgtPA/mL. The
tPA working solution (0.1 mgtPA/mL) were diluted 1:20,
1:16.6, and 1:13.3, respectively. SPION stock solutions
(3 mgFe/mL) and the supernatants of the SPION prepara-
tions were diluted to 1:16.6 and 1:1.6, respectively using
sterile deionized H2O. Fifty microliters of diluted tPA and
SPION samples were pipetted in quadruplicates into a 96-
well cell culture plate mixed with 100 μL assay buffer
(1 mM S-2288 in 0.1 M Tris-HCl pH 8.4). The kinetic of
the reaction were recorded by measuring the absorption
at 405 nm in a spectrophotometer (FilterMax F5, Molecu-
lar Devices, Sunnyvale, CA, USA) overnight. To compare
SPION-containing and SPION-free samples, the data of
SPION-containing samples were subtracted with the value
given by the difference in the starting absorption of sam-
ples with SPIONs and control samples.
Determination of tPA Activity with Fibrin-Agarose Gels
The activity of tPA was determined by fibrin clot lysis
assay using fibrin-containing agarose plates [23, 24]. The
plates were prepared by mixing 25 mL agarose solution
(3 % in TBS; agarose low melt, # 6351, Carl Roth GmbH,
Germany) containing 5 U thrombin (thrombin, # T7009-
100 U; dissolved in 1 mL distilled H2O; Sigma-Aldrich,
USA) with 12.5 mL fibrinogen solution (3 mg/mL in
TBS; fibrinogen, F3879; Sigma-Aldrich, USA) at 37 °C.
The reaction mix was poured into a 1-well cell culture
plate (Greiner Bio-One, Cellstar OneWell Plate, #
670180) equipped with a 24 pin tool with a pin diameter
of 3 mm and incubated at 37 °C for 2 h to allow fibrin
clot formation, followed by cooling at 4 °C for 1 h. After
carefully removing the pin tool, the fibrin-agarose gel
with the emerging holes were filled with 20 μL sample
and incubated at 37 °C overnight. The degree of clot
lysis was estimated by comparing the size of the fibrin-
olysis zone around the samples.
Cell Culture and Sample Preparation
Cell Cultivation
Primary human umbilical vein endothelial cells (HUVECs)
were purchased from PromoCell (Heidelberg, Germany).
In all experiments, HUVECs pooled from four donors
were used at passage 3–5 which corresponds to 12–20 cell
divisions. HUVECs were cultivated in enhanced endothe-
lial cell growth medium from PELOBiotech (Planegg,
Germany) at 37 °C and 5.0 % CO2. For further passaging,
trypsinization was performed according to the manufac-
turer’s instructions.
Cell-Based Experiment Preparation
3.2 × 105 HUVECs were seeded into 25 cm2 cell culture
plates. After 24 h, SPIONs (PAM-SPIONs, covalent
tPA@PAM-SPIONs, and adsorbed tPA@PAM-SPIONs)
were added to a final concentration of 30 μgFe/mL cell
culture media which corresponds to 7.2 μgFe/cm
2 cell
culture plate area. Thus, the correlation between the
SPION concentration in cell culture media and on the
plate surface area was kept constant for all experiments.
Cells were incubated with SPIONs for another 48 h
followed by harvesting. The cell pellets were washed
twice with PBS and resuspended in 0.5 mL PBS. Cell
suspensions were used to determine the absolute cell
counts and viability with the MUSE® Cell Analyzer
(Merck-Millipore, Billerica, USA), as well as for flow cy-
tometry analysis and SPION quantification measure-
ments using AES spectroscopy (see below).
In Vitro Toxicity on Human Umbilical Vein Endothelial Cells
(HUVECs)
Analysis of HUVECs Using Flow Cytometry Flow cy-
tometry was performed using a Gallios cytofluorometer
(Beckman Coulter, Fullerton, CA, USA) in order to analyze
cell morphology (FSc and SSc) and cell viability [25, 26].
For cell death analysis, 50 μL aliquots of cell suspension
were incubated with 250 μL of freshly prepared staining
solution containing 1 μg/mL annexin V-FITC, 1 μg/mL
Hoechst 33342, and 5.1 μg/mL 1,1′,3,3,3′,3′-hexamethy-
lindodicarbocyanine iodide (DiIC1(5)) (all from Thermo
Fisher Scientific, Waltham, MA, USA), 20 μg/mL propi-
dium iodide (Sigma-Aldrich, Taufkirchen, Germany) in
Ringer’s solution (Baxter Healthcare, Zurich, Switzerland)
for 20 min at 4 °C.
SSc was extracted from the flow cytometric measure-
ments after gating on phenotypically healthy cells, char-
acterized by annexin V negative and propidium iodide
negative staining. Every sample was measured for a fixed
time (120 s).
For the analysis of cell cycle and DNA degradation,
further 200 μL of the cell suspensions were fixed by
adding 3 mL of 70 % (v/v) ice-cold ethanol and
stored at −20 °C for further processing. The cells
were then centrifuged (5 min, 1000g, 4 °C), the super-
natant was removed, and the cells were washed with
PBS once. Then the cells were resuspended in 0.5 mL
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PBS, and 0.5 mL DNA extraction buffer (192 mL of 0.2 M
Na2HPO4, 8 mL 0.1 % Triton X-100 (v/v), pH 7.8) was
added and incubated for 5 min at RT. Cells were centri-
fuged (5 min, 1000g, 4 °C), the supernatant was removed,
and cells were resuspended in 1 mL PIT DNA staining so-
lution (50 μg/mL propidium iodide in water and 1 mg/mL
sodium citrate, 0.1 % Triton X-100 (v/v),) and incubated
for 30 min in the dark. Electronic compensation was used
to eliminate bleed through fluorescence. Data analysis was
performed with Kaluza software version 2.0 (Beckman
Coulter). All flow cytometry analyses were performed in
quadruplicates.
Quantification of Cellular SPIONs by Atomic Emission
Spectroscopy (AES)
The absolute iron content was determined by microwave
plasma-atomic emission spectrometer (MP-AES) using
an Agilent 4200 MP-AES (Agilent Technologies, Santa
Clara, CA). Cell suspensions with 2 × 105 cells were cen-
trifuged for 5 min at 500g. The supernatants were
aspirated and the pellets stored at −20 °C until measure-
ment. The cell pellets were then dissolved in 0.5 mL ni-
tric acid 65 % overnight and diluted to 4 mL with
ultrapure water. The total iron content of the cells was
then determined using the MP-AES method which was
described above. The iron content was normalized to
the total number of cells in the analyzed cell pellet.
Results
Production of tPA-Containing Nanoparticles
Influence of Solvent and Ultrafiltration of tPA Solutions on
tPA Activity
In order to couple proteins to polyacrylic acid-co-maleic
acid (PAM)-coated SPIONs using an amino-reactive ester
reaction, the protein solution should be free of other
compounds with reactive NH2-groups. The commercially
available tPA formulation Actilyse® contains 38.5 mg/mL
of the amino acid arginine. Arginine bears at least two free
primary amine groups which could possibly react with the
activated o-acylisourea esters during the EDC/NHS coup-
ling. This could impede the reaction efficacy of tPA to the
particle surface. Therefore, we purified the formulations
before usage.
To remove the excess of inactive substances, we estab-
lished a TFF method using a Spectrum Labs KrosFlo®
Research II TFF unit with modified polyethersulfone
(mPES) hollow fibre filters. HEPES buffer 0.3 M proved
to be one of the few solvents in which the protein was
sufficiently stable during filtration. We compared the ac-
tivity of stabilized tPA, tPA dissolved in HEPES filtration
buffer and ultrafiltrated tPA in HEPES filtration buffer
(Additional file 1: Figure S1). The tPA activity was high-
est when dissolving the lyophilized protein in water as
described by the manufacturer. Changing the solvent to
HEPES reduces the activity to 80 % which is further re-
duced by the ultrafiltration process to 49 %.
Production of Covalent and Non-covalent Functionalized
SPIONs
A simplified reaction scheme of our approach to covalently
immobilize tPA on the PAM-coated SPIONs is displayed
in Fig. 1. EDC/NHS coupling of proteins to carboxylated
surfaces is a well-studied reaction [22]. Due to their high
surface-to-volume ratio and surface curvature, nanoparti-
cles often exhibit a different chemistry as far as reaction
parameters are concerned [27]. It is therefore important to
evaluate reaction parameters case-by-case. Grafting of mol-
ecules to SPION surfaces can influence their surface prop-
erties and, consequently, their stability. Measurements of
hydrodynamic size at a constant time point after redisper-
sion can provide information about changes in stability in
tandem with pH-dependent electrokinetic mobility mea-
surements [21]. In this study, we used this method to dem-
onstrate the dependence of colloidal parameters on the
reaction conditions after binding of tPA.
Differences in tPA-Binding Efficiencies on Covalent and
Non-covalent Functionalized SPIONs
We estimated the tPA binding efficiency of three independ-
ent covalent and non-covalent reactions by determining the
remaining tPA protein and tPA activity in the collected
supernatant of the reaction mix and the washing steps
(Fig. 2). The total tPA protein content in the supernatant
were analyzed by Coomassie and silver staining after SDS-
PAGE (Fig. 2a, b). In contrast to the supernatant which
were collected during the covalent reaction, the super-
natant of the adsorption contained detectable amounts of
tPA, indicating a significantly higher tPA load on particles
after the covalent reaction (Fig. 2a, b). Quantification of the
SDS-PAGE using image J revealed an adsorption of 47.7 ±
5.4 % of the applied tPA, whereas 98.6 ± 0.8 % was bound
to the SPIONs after covalent reaction. We confirmed the
different binding efficiencies indirectly by measurement of
the tPA activity in the supernatant using the S-2288 activity
assay (Fig. 2c, d). Only a minimal activity was left in the
supernatant of the covalently functionalized particles, indi-
cating that almost all tPA, added to the activated reaction
mixes, were bound to the particles. In contrast, the super-
natant of the adsorption reactions still exhibits clear enzym-
atic activity, which was approximately 21.4-fold higher than
the supernatant of the covalent reaction mixes. This indi-
cates a superior protein binding rate to nanoparticles with
activated carboxyl groups.
Physico-chemical Characterization of Functionalized
Nanoparticles
We then evaluated the influence of tPA concentration
and reaction time on the PAM-SPIONs using dynamic
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light scattering (DLS) (Fig. 3). The hydrodynamic par-
ticle size of the reacted tPA@PAM-SPIONs which was
measured at constant time points after sonication
(60 s) increases with good correlation to the tPA
amount. The adsorption control does not show such
behavior. As the size increase is a direct consequence
of a change in surface properties, this could indicate
successful surface modification after 3 h of reaction
time (Fig. 3a). The high standard deviations for the
samples reacted with 500 μg/mL tPA already indicate
rapid sedimentation. Figure 3b shows that this effect
is also reaction-time dependent. The tPA concentra-
tion which was used here was 500 μg/mL. Seemingly,
this effect is only taking place during the first 3 h of
the reaction. To investigate the changes in the surface
properties, we performed pH-dependent electrokinetic
mobility measurements on tPA@PAM-SPIONs which
reacted or adsorbed for 3 h with 250 μg/mL of tPA
(Fig. 3c). Such measurements allow comparison of the
surface properties of colloids [21, 28]. The PAM-
coated SPIONs display a negative surface charge
which begins to decrease at pH 4 and below until
reaching the isoelectric point (IEP) at around pH 2.
This is in concordance with previous results [21]. tPA
addition leads to a shift in the IEP towards pH 3. As
the isoelectric point of tPA is about 7.7, this could in-
dicate a successful surface binding of the protein [29].
Furthermore, at pH 2, tPA@PAM-SPIONs bear a
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positive surface charge of 15.52 ± 0.83 mV, which is
not possible for PAM polymer.
Interestingly, in Fourier transform infrared spectroscopy
(FTIR), the tPA could not be detected in tPA@PAM-
SPIONs even at tPA loading concentrations of 500 μg/mL
(Additional file 1: Figure S2). We attribute this to the low
molar ratio of tPA relative to iron or polymer.
Nonetheless, taken together, these measurements clearly
show the different nature of covalently bound and
adsorbed tPA protein on the surface of PAM-SPIONs.
tPA Activity of Functionalized SPIONs with Covalent and
Non-covalent tPA
The decision for a non-covalent or covalent approach is
highly dependent of the expected activity of the attached
drug at a specific location. Adsorbed proteins might be
of advantage because they quickly release the drug at a
particular site and with higher penetration through tis-
sues. Covalent strategies might be more effective using
drugs that covalently bound to particles, e.g., when the
drug must act exclusively at a single location or must be
forced into other matrices. Here, we investigated the ac-
tivity of freshly manufactured particles in solution and in
fibrin matrices and compared the results with the activ-
ity measured after long time storage at 4 °C (Fig. 4).
We first determined the activity of three independently
and freshly manufactured particles with covalent and
non-covalent attached tPA using the S-2288 assay
(Fig. 4a, c). As expected from the results achieved with
the supernatant of the reaction mixes (Fig. 2), covalently
bound particles possessed strong enzymatic activity,
even stronger than a pure 0.1 mg/mL stabilized tPA con-
trol. Considering the dilution of the samples, the tPA ac-
tivity of particles with covalently bound tPA is in average
40 % higher than the activity of a 0.1 mg/mL stabilized
tPA solution. In contrast, the adsorptive approaches de-
liver particles with a tPA activity of 22 % if compared to
the tPA control (Fig. 4a, c). Hence, the activity of
SPIONs with covalently bound tPA is 6.4-fold higher
than the non-covalent approach of tPA binding.
To investigate the effects of long time storage, we kept
the particles at 4 °C and repeated the experiments after
40 days (Fig. 4b, c). Remarkably, the particles with cova-
lently bound tPA still exhibit 63 % activity compared to
the tPA control samples, whereas the SPIONs with
adsorbed tPA were absent of any remaining tPA activity
as measured by the S-2288 assay, indicating an effective
stabilization of tPA when covalently bound to a matrix.
We then used a fibrin-agarose assay to investigate the
behavior of these SPIONs within a matrix and to evalu-
ate the fibrinolytic activity of the functionalized SPIONs
(Fig. 4d, f ). Both particle systems showed the ability to
diffuse into the fibrin-agarose matrix and lysate fibrin fi-
bers. After 24 h, the lysis distance induced by adsorbed
tPA@PAM-SPIONs was 19 % larger than those induced
by covalent tPA@PAM-SPIONs, despite higher tPA load-
ing and activity of covalent tPA@PAM-SPIONs (Fig. 4d,
f ). This may already indicate better liberation of tPA
from the particles, which may also be beneficial in
thrombolysis. Most likely, adsorbed tPA@PAM-SPIONs
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release small quantities tPA with a considerably higher
matrix-diffusion capability. The results of the fibrin-
agarose assay significantly changed with aged particles
(Fig. 4e, f ). While covalent tPA@PAM-SPIONs still
shows 74 % of its original activity, the distance of the fi-
brinolysis zone of adsorbed tPA@PAM-SPIONs dropped
to 18 %, confirming the findings of the S-2288 assays.
Toxicity and Cellular Uptake of tPA-Containing
Nanoparticles
Finally, we performed toxicity and cellular uptake experi-
ments to examine possible differences in the cellular re-
sponse to covalent and non-covalent particles. Human
umbilical vein endothelial cells (HUVECs) were incubated
with 30 μgFe/mL SPIONs for 48 h. After cell harvesting
and counting using the MUSE cell analyzer, toxicity and
content of intracellular and cell-associated SPIONs were
determined by flow cytometry and microwave plasma-
atomic emission spectrometer (MP-AES), respectively
(Additional file 1: Figure S3).
Flow cytometry is an accurate technology to analyze cell
morphology and cell viability [26, 30–35]. To find possible
differences between covalent and non-covalent binding
approaches, we performed a multiparameter flow cytome-
try assay (Additional file 1: Figure S3A–D). After incuba-
tion of HUVECs with different particles, a detailed
analysis of the membrane potential by DiIC1(5) staining
and the viability by annexin V and propidium iodide
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staining revealed only very slight, non-significant cellular
effects compared with control samples (Additional file 1:
Figure S3A, B). Merely the propidium iodide-TritonX
measurements for the investigation of cell cycle and DNA
degradation showed a slightly enhanced DNA degradation
in SPION-treated samples, compared to control samples
(Additional file 1: Figure S3 C). However, differences
between tPA-free and tPA-containing SPIONs were not
detectable with the examined parameters, indicating that
HUVECs only respond to the SPION-load and were un-
able to differentiate between tPA-loaded or unloaded
SPIONs, given that the cellular interaction with the ap-
plied SPIONs is equal. We therefore evaluated the cellular
SPION load of the obtained cell suspensions by flow cy-
tometry, as the amount of cellular uptake has been shown
to correlate with the flow cytometry analysis of the side
scatter [25]. As expected, the determination of the side
scatter revealed very similar results of cells incubated with
the employed particle systems (Additional file 1: Figure
S3D). To confirm these findings, we investigated aliquots
of the cell suspension with MP-AES (Additional file 1:
Figure S3E). After normalizing the iron content to the cell
numbers, we found no significant differences between the
cellular uptake of PAM-SPIONs, covalent tPA@PAM-
SPIONs and adsorbed tPA@PAm-SPIONs, resembling the
data received from flow cytometry and indicating that the
tPA shell is not influencing the uptake of particles into
HUVECs.
Discussion and Conclusion
Iron oxide nanoparticles are frequently used within
medicine, biotechnology, and catalysis. While the core
material particularly determines the physical properties
such as size, crystal structure, and mainly magnetic fea-
tures, the shell is primarily responsible for the biological
function of the particle system besides its inherent role
in inhibiting particle aggregation [13, 14, 21, 36]. The
functionalization of particles with biologically active
compounds can be achieved by covalent or non-covalent
binding strategy. Since the conjugation of drugs can
affect the particle surface, it can lead to deviant behavior
between particles with covalently linked and adsorptive
bound drugs. Consequently, this influences the in vitro
and in vivo behavior, biocompatibility, stability, and solu-
bility and needs to be considered early during the design
of new nanoparticles [15, 21]. Moreover, depending on
the intended application, the two approaches might have
both advantages and disadvantages and have to be
weighed very carefully. Often it is difficult if not impos-
sible to predict the properties before manufacturing,
making it advisable to produce both versions and to
choose the best one after extensive characterization. An
elucidatory example is tPA-decorated particles against
thrombosis. The ideal tPA-functionalized particle should
be chemically and colloidally stable, biocompatible,
non-toxic, controllable by an external magnetic field,
enzymatically active on fibrin matrices, and display the
ability to allow deeper penetration of tPA into fibrin
matrices or thrombi.
In this study, we manufactured particles with cova-
lent and non-covalent bound tPA. While the super-
natant of ads. tPA@PAM-SPIONs still displayed
significant fibrinolytic activity, which we attribute to
unbound tPA, the supernatant of cov. tPA@PAM-
SPIONs showed no such effect, indicating that cova-
lent binding using an active ester reaction led to
higher binding rates. Accordingly, SDS-PAGE deter-
mination of supernatants showed free tPA only in
samples following adsorbed tPA binding (Fig. 2).
Covalent or non-covalent binding of proteins onto nano-
particles can significantly alter the structure and function of
the involved proteins and can in some cases be monitored
by FTIR [37–39]. This detection is strongly limited by the
signal-to-noise ratio and the mass ratio between nanoparti-
cle and protein. In case of tPA@PAM-SPIONs, the protein
is not detectable by FTIR (Additional file 1: Figure S2).
However, we were able to show that covalently attached
tPA significantly affects the surface chemistry of PAM-
SPIONs (Fig. 3c). The IEP of cov. tPA@PAM-SPIONs is
clearly shifted towards the IEP of pure tPA compared to
PAM-SPIONs. Furthermore, positive zeta potentials can be
achieved at low pH. This tPA amount-dependent change in
surface charging leads to destabilization of the colloid.
Measuring the hydrodynamic size of particle aggregates at
constant time points after ultrasonication, we could
show that the destabilization depends on the amount
of protein used (Fig. 3a) and on the reaction time
(Fig. 3b). The surface charging of ads. tPA@PAM-
SPIONs is not affected, and therefore, the adsorbed
particles show no such instability.
Monitoring the tPA activity of the particles using the
S-2288 assay, we showed that the cov. tPA@PAM-
SPIONs show significantly higher fibrinolytic activity
than the ads. tPA@PAM-SPIONs in vitro (Fig. 4a). Inter-
estingly, the fibrinolytic activity of cov. tPA@PAM-
SPIONs was comparable to that of free tPA. This is
surprising, because proteins have the tendency to adsorb
to surfaces, resulting in a loss of significant amounts of
tPA on filters and hose system during the necessary
ultrafiltration process and so in a decrease in their meas-
urable activity. We found that these issues result in loss
of around 50 % activity after reconstitution in HEPES
buffer and ultrafiltration compared to reconstitution in
distilled water as shown in Additional file 1: Figure S1.
Interestingly, the high difference in tPA activity could
not be verified within agarose-fibrin matrices, where the
effect of both particle systems were very similar (Fig. 4d).
Most likely, the adsorptive bound tPA detaches from the
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particles and diffuses more readily into the matrix than
covalently bound tPA. However, particles with covalently
bound tPA seem hypothetically more suitable for
magnetic drug targeting, as those particles can be di-
rected to and into a thrombus without stripping off
the bioactive tPA enzyme. This topic will be investi-
gated in detail in future studies.
Another issue and one of the most crucial problems of
producing tPA-containing medicines is the long term sta-
bility. According to the manufacturer, reconstituted tPA
solutions are only stable 24 h at 2–8 °C. However, the
elapsed time between manufacturing, storage, delivery,
and application of tPA particles is significantly longer.
Interestingly, tPA conjugated to SiO2-magnetic nanoparti-
cles showed an enhanced storage stability up to 9.5-fold in
buffer and 2.8-fold in whole blood [24]. To test whether
our particles show similar stability, we measured the activ-
ity after 40 days to evaluate the long time stability of tPA
(Fig. 4b). Impressively, particles with covalently bound tPA
still have 49 % of the original activity, whereas the activity
of the adsorptive bound tPA is not measurable with the S-
2288 assay (Fig. 4c). Similar results were achieved using
the agarose-fibrin assay (Fig. 4d–f). The ability of covalent
tPA@PAM-SPIONs to penetrate into and dissolve the fi-
brin network was only reduced by 26 %, while adsorptive
tPA@PAM-SPIONs revealed a reduction of 72 % (Fig. 4f).
In summary, the tPA loading efficiency, the enzymatic
activity, and the longtime stability of covalent tPA@-
PAM-SPIONs is much more pronounced than with
adsorptive tPA@PAM-SPIONs.
Additional file
Additional file 1: Figure S1. The influence of buffer and diafiltration
on the activity of different tPA concentration and dilutions measured
with the chromogenic S-2288 activity assay. (A) Kinetic of H2O-diluted
tPA and buffer-diluted tPA before and after ultrafiltration determined by
the hydrolysation of S-2288 and the arising p-nitroaniline absorption. (B)
tPA activity calculated by the absorption change of p-nitroaniline
emerging within the first 2 h during the kinetics shown in (A). Figure S2:
FTIR of particles. Spectra from 4000 to 400cm−1 of pure tPA (blue), PAM-
SPIONs (red) and covalent tPA@PAM-SPIONs (green). The iron oxide peak
at 584 cm−1 is clearly visible in the particle containing samples, also the
carboxyl peak of PAM can be seen in the polymer containing samples at
1625 cm−1. Compared to the PAM-SPION spectrum, there is no concise
tPA-derived peak visible within the tPA@PAM-SPIONs spectrum. Figure S3.
Cellular effects of tPA particles. (A) Membrane integrity analyzed by DiIC1(5)
staining. (B) Cell viability determined by annexin V/propidium iodide
staining. (PI+) necrotic/late apoptotic cells, (AxV+, PI−) early apoptotic cells,
(AxV−, PI−) viable cells. (C) DNA cycle and DNA degradation determined by
propidium iodide/tritonX analysis (PIT). The results were normalized to
untreated control cells, set to 100 %. (D) Cellular iron uptake in HUVECs
determined by flow cytometry analyses of the side scatter. (E) Cellular iron
uptake in HUVECs determined by atomic emission spectroscopy (AES).
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